Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
110.50    0.00 (0.00%)
Bid:
109.00
Ask:
112.00
Spread: 3.00 (2.752%)
Market Cap: £66.48m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Directorate Change

31 Mar 2006 12:00

Intercede Group PLC31 March 2006 31 MARCH 2006 INTERCEDE GROUP PLC BOARD CHANGES Intercede Group plc (the "Company") is pleased to announce that it has appointedJacques Tredoux as a non-executive director of the Company, with effect from 31March 2006. Jacques Tredoux, aged 42, is the Chief Executive of Tredoux Capital Limited, acompany authorised by the Financial Services Authority to provide corporatefinance advisory services. Prior to establishing Tredoux Capital Limited, Jacques was the Chief ExecutiveOfficer of the Credo Group (UK) Limited, a group of companies in London thatprovides wealth management services. Members of the Credo Group have providedcorporate finance and fundraising assistance to the Company since prior to itsadmission to AIM. Jacques remains a director of Credo Group Holdings Limited. Jacques Tredoux qualified as a lawyer in 1988 in South Africa, and practised atEdward Nathan & Friedland Inc and Clifford Chance. Following the appointment of Jacques Tredoux, the Company also announces thatGreg Roediger has resigned as a non-executive director of the Company. Richard Parris, Chairman & CEO of the Company, commented: "We are extremely pleased that Jacques has agreed to join Intercede. He has awealth of legal, commercial and financial services experience which will be ofenormous value to us as we continue to expand and develop our network ofbusiness relationships across the world. "The Board would also like to take the opportunity to thank Greg for hisvaluable contribution to the Company's development over the past six years." APPENDIX The directorships held by Mr Tredoux over the five years preceding the date ofthis announcement other than in the Company are as follows: Current Directorships Companies registered in England & Wales: Tredoux Capital Limited Berkeley Corporation Limited Berkeley Management & Finance Limited Credo.com Limited Credo Advisory Services Limited Credo Corporate Finance Limited Credo Capital plc Credo Financial Solutions (UK) Limited Credo Group (UK) Limited Credo Guarantees Limited Credo Property Group Limited Credo Property Investments Limited Credo Property Management Limited Hooper Investments Limited Plastic Medical (Supplies) Limited Companies registered overseas: Credo Group Holdings Limited (Bermuda) Credo Australia Pty Limited (Australia) Credo Properties International Limited (Bermuda) Credo Sterling Properties UK Limited (BVI) San Mackenzie Enterprises Limited ("San Mackenzie") owns 1,463,216 shares whichrepresents 4.3% of the Company's issued share capital. San Mackenzie iscontrolled by The Woodcock Trust, of which Jacques Tredoux is a potentialbeneficiary. Jacques Tredoux has confirmed to the Company that there is no other informationrequired to be disclosed pursuant to the AIM Rules. About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). The Group's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates and Open Platformapplets. Intercede's customers cover a range of industries and include Athena SmartcardSolutions, Department of Transport Ireland, Fujitsu, Getronics PinkRoccade,GemPlus, Lloyds TSB, UK National Health Service (NHS), UK Metropolitan Police,Oberthur Card Systems, RSA Security, Royal Bank of Scotland, SafeNet, Siemens,Thales, Ubizen, VeriSign and various US and UK Government agencies anddepartments. For more information, visit www.intercede.comIntercede and MyID are registered trademarks or trademarks in the UK and/or other countries. ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public Relations Tel. +44 (0)20 7743 6679Archie Berens This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
26th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.